Celularity (CELUW) Net Cash Flow (2019 - 2025)
Celularity (CELUW) reported Net Cash Flow of $6.1 million for Q4 2025, up 846.9% year-over-year from $646000.0 in Q4 2024, and up 998.24% quarter-over-quarter from -$681000.0 in Q3 2025.
Celularity (CELUW) Net Cash Flow (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Net Cash Flow data on file, last reported at $6.1 million in Q4 2025.
- Net Cash Flow for Q4 2025 came in at $6.1 million, up 846.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.4 million (up 562.78% YoY), and the FY2025 annual result was $5.4 million, up 562.78% from the prior year.
- Net Cash Flow grew to $6.1 million in Q4 2025 per CELUW's latest filing, from -$681000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $64.5 million in Q3 2021 and troughed at -$35.4 million in Q4 2021.
- A 5-year average of -$2.7 million and a median of -$1.0 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow slumped 7520.18% in 2021, then soared 846.9% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$35.4 million in 2021, then grew by 18.9% to -$28.7 million in 2022, then surged by 82.79% to -$4.9 million in 2023, then soared by 113.09% to $646000.0 in 2024, then soared by 846.9% to $6.1 million in 2025.
- Business Quant data shows CELUW's Net Cash Flow at $6.1 million in Q4 2025, -$681000.0 in Q3 2025, and $632000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Celularity | - | - | -3.27 Mn | 6.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.12 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | -681,000.00 |
| Sep 30, 2025 | -681,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | -673,000.00 |
| Mar 31, 2025 | -673,000.00 |
| Dec 31, 2024 | 646,000.00 |
| Dec 31, 2024 | 646,000.00 |
| Sep 30, 2024 | -223,000.00 |
| Sep 30, 2024 | -223,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Dec 31, 2023 | -4.94 Mn |
| Dec 31, 2023 | -4.94 Mn |
| Sep 30, 2023 | -2.81 Mn |
| Sep 30, 2023 | -2.81 Mn |